Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1990;17(3):203–215.

Review of the Pharmacology, Pharmacokinetics, and Clinical Use of Cephalosporins

Debra Kalman 1, Steven L Barriere 1
PMCID: PMC324918  PMID: 15227172

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge K. E. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp. Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):45–50. doi: 10.1016/0732-8893(89)90045-x. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. A. Cross-sensitivity to cephalosporins in patients allergic to penicillin. Pediatr Infect Dis. 1986 Sep-Oct;5(5):557–561. doi: 10.1097/00006454-198609000-00013. [DOI] [PubMed] [Google Scholar]
  3. Arditi M., Herold B. C., Yogev R. Cefuroxime treatment failure and Haemophilus influenzae meningitis: case report and review of literature. Pediatrics. 1989 Jul;84(1):132–135. [PubMed] [Google Scholar]
  4. Aronoff S. C., Shlaes D. M. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa. J Infect Dis. 1987 May;155(5):936–941. doi: 10.1093/infdis/155.5.936. [DOI] [PubMed] [Google Scholar]
  5. Barriere S. L., Conte J. E., Jr Emergence of multiple antibiotic resistance during the therapy of Klebsiella pneumoniae meningitis. Am J Med Sci. 1980 Jan-Feb;279(1):61–65. doi: 10.1097/00000441-198001000-00009. [DOI] [PubMed] [Google Scholar]
  6. Barriere S. L., Flaherty J. F. Third-generation cephalosporins: a critical evaluation. Clin Pharm. 1984 Jul-Aug;3(4):351–373. [PubMed] [Google Scholar]
  7. Barriere S. L. Nephrotoxicity of cephalothin-aminoglycoside interactions. Arch Intern Med. 1982 Sep;142(9):1754–1754. [PubMed] [Google Scholar]
  8. Barson W. J., Miller M. A., Brady M. T., Powell D. A. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children. Pediatr Infect Dis. 1985 Jul-Aug;4(4):362–368. doi: 10.1097/00006454-198507000-00006. [DOI] [PubMed] [Google Scholar]
  9. Bergan T. Pharmacokinetic properties of the cephalosporins. Drugs. 1987;34 (Suppl 2):89–104. doi: 10.2165/00003495-198700342-00008. [DOI] [PubMed] [Google Scholar]
  10. Bradsher R. W. Relapse of gram-negative bacillary meningitis after cefotaxime therapy. JAMA. 1982 Sep 10;248(10):1214–1215. [PubMed] [Google Scholar]
  11. Brogden R. N., Campoli-Richards D. M. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential. Drugs. 1989 Oct;38(4):524–550. doi: 10.2165/00003495-198938040-00004. [DOI] [PubMed] [Google Scholar]
  12. Bryan J. P., Rocha H., da Silva H. R., Taveres A., Sande M. A., Scheld W. M. Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother. 1985 Sep;28(3):361–368. doi: 10.1128/aac.28.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chambers H. F., Mills J., Drake T. A., Sande M. A. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis. 1984 Nov-Dec;6 (Suppl 4):S870–S874. doi: 10.1093/clinids/6.supplement_4.s870. [DOI] [PubMed] [Google Scholar]
  14. Chin N. X., Neu H. C. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):21S–31S. [PubMed] [Google Scholar]
  15. Cohen M. S., Washton H. E., Barranco S. F. Multicenter clinical trial of cefoperazone sodium in the United States. Am J Med. 1984 Jul 31;77(1B):35–41. doi: 10.1016/s0002-9343(84)80094-7. [DOI] [PubMed] [Google Scholar]
  16. Collier A. C., Judson F. N., Murphy V. L., Leach L. A., Root C. J., Handsfield H. H. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women. Am J Med. 1984 Oct 19;77(4C):68–72. [PubMed] [Google Scholar]
  17. Congeni B. L. Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrob Agents Chemother. 1984 Jan;25(1):40–44. doi: 10.1128/aac.25.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Darbyshire P. J., Williamson P. J., Pedler S. J., Speller D. C., Mott M. G., Oakhill A. Ceftazidime in the treatment of febrile immunosuppressed children. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):357–360. doi: 10.1093/jac/12.suppl_a.357. [DOI] [PubMed] [Google Scholar]
  19. Donowitz G. R., Mandell G. L. Drug therapy. Beta-lactam antibiotics (2). N Engl J Med. 1988 Feb 25;318(8):490–500. doi: 10.1056/NEJM198802253180806. [DOI] [PubMed] [Google Scholar]
  20. Donowitz G. R. Third generation cephalosporins. Infect Dis Clin North Am. 1989 Sep;3(3):595–612. [PubMed] [Google Scholar]
  21. Drusano G. L., Warren J. W., Saah A. J., Caplan E. S., Tenney J. H., Hansen S., Granados J., Standiford H. C., Miller E. H., Jr A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet. 1982 May;154(5):715–720. [PubMed] [Google Scholar]
  22. Dworzack D. L., Pugsley M. P., Sanders C. C., Horowitz E. A. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins. Eur J Clin Microbiol. 1987 Aug;6(4):456–459. doi: 10.1007/BF02013110. [DOI] [PubMed] [Google Scholar]
  23. Eichenwald H. F. Antimicrobial therapy in infants and children: update 1976-1985. Part I. J Pediatr. 1985 Aug;107(2):161–168. doi: 10.1016/s0022-3476(85)80118-9. [DOI] [PubMed] [Google Scholar]
  24. Fainstein V., Bodey G. P., Elting L., Bolivar R., Keating M. J., McCredie K. B., Valdivieso M. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):101–110. doi: 10.1093/jac/12.suppl_a.101. [DOI] [PubMed] [Google Scholar]
  25. Fong I. W., Tomkins K. B. Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime. Rev Infect Dis. 1985 Sep-Oct;7(5):604–612. doi: 10.1093/clinids/7.5.604. [DOI] [PubMed] [Google Scholar]
  26. Funk E. A., Strausbaugh L. J. Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone. Pharmacotherapy. 1982 Jul-Aug;2(4):185–196. doi: 10.1002/j.1875-9114.1982.tb03186.x. [DOI] [PubMed] [Google Scholar]
  27. Galask R. P., Weiner C., Petzold C. R. Comparison of single-dose cefmetazole and cefotetan prophylaxis in women undergoing primary caesarean section. J Antimicrob Chemother. 1989 Apr;23 (Suppl 500):105–108. doi: 10.1093/jac/23.suppl_d.105. [DOI] [PubMed] [Google Scholar]
  28. Gaskill H. V., 3rd, Levine B. A. A randomized prospective study of antibiotic prophylaxis during abdominal surgery. J Antimicrob Chemother. 1989 Apr;23 (Suppl 500):79–83. doi: 10.1093/jac/23.suppl_d.79. [DOI] [PubMed] [Google Scholar]
  29. Geckler R. W., Eng R. H., Fabian T. C., Echols R. M., Jemsek J. G., LeFrock J. L., Mogabgab W. C., Wilson S. E. A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue. Am J Surg. 1988 May 31;155(5A):91–95. doi: 10.1016/s0002-9610(88)80221-6. [DOI] [PubMed] [Google Scholar]
  30. Gentry L. O. Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime. Pharmacotherapy. 1985 Sep-Oct;5(5):254–267. doi: 10.1002/j.1875-9114.1985.tb03424.x. [DOI] [PubMed] [Google Scholar]
  31. Goldberg D. M. The cephalosporins. Med Clin North Am. 1987 Nov;71(6):1113–1133. [PubMed] [Google Scholar]
  32. Gottlieb A., Mills J. Cefuroxime axetil for treatment of uncomplicated gonorrhea. Antimicrob Agents Chemother. 1986 Aug;30(2):333–334. doi: 10.1128/aac.30.2.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Griffith D. L., Novak E., Greenwald C. A., Metzler C. M., Paxton L. M. Clinical experience with cefmetazole sodium in the United States: an overview. J Antimicrob Chemother. 1989 Apr;23 (Suppl 500):21–33. doi: 10.1093/jac/23.suppl_d.21. [DOI] [PubMed] [Google Scholar]
  34. Handsfield H. H., Murphy V. L. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men. Lancet. 1983 Jul 9;2(8341):67–70. doi: 10.1016/s0140-6736(83)90058-2. [DOI] [PubMed] [Google Scholar]
  35. Howie V. M., Owen M. J. Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media. Pediatr Infect Dis J. 1987 Oct;6(10):989–991. doi: 10.1097/00006454-198710000-00040. [DOI] [PubMed] [Google Scholar]
  36. Iravani A., Richard G. A., Johnson D., Bryant A. A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. Am J Med. 1988 Sep 16;85(3A):17–23. doi: 10.1016/0002-9343(88)90459-7. [DOI] [PubMed] [Google Scholar]
  37. Jacobs R. F., Wells T. G., Steele R. W., Yamauchi T. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children. J Pediatr. 1985 Jul;107(1):129–133. doi: 10.1016/s0022-3476(85)80634-x. [DOI] [PubMed] [Google Scholar]
  38. Jagelman D. G., Fabian T. C., Nichols R. L., Stone H. H., Wilson S. E., Zellner S. R. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery. Am J Surg. 1988 May 31;155(5A):71–76. doi: 10.1016/s0002-9610(88)80217-4. [DOI] [PubMed] [Google Scholar]
  39. Jimenez-Lucho V. E., Saravolatz L. D., Medeiros A. A., Pohlod D. Failure of therapy in pseudomonas endocarditis: selection of resistant mutants. J Infect Dis. 1986 Jul;154(1):64–68. doi: 10.1093/infdis/154.1.64. [DOI] [PubMed] [Google Scholar]
  40. Jones R. N., Barry A. L., Packer R. R. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):37S–46S. [PubMed] [Google Scholar]
  41. Jones R. N. Review of the in-vitro spectrum and characteristics of cefmetazole (CS-1170). J Antimicrob Chemother. 1989 Apr;23 (Suppl 500):1–12. doi: 10.1093/jac/23.suppl_d.1. [DOI] [PubMed] [Google Scholar]
  42. Kenna M. A., Bluestone C. D., Fall P., Stephenson J., Kurs-Lasky M., Wucher F. P., Blatter M. M., Reisinger K. S. Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children. Pediatr Infect Dis J. 1987 Oct;6(10):992–996. doi: 10.1097/00006454-198710000-00041. [DOI] [PubMed] [Google Scholar]
  43. Kernodle D. S., Classen D. C., Burke J. P., Kaiser A. B. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA. 1990 Feb 16;263(7):961–966. [PubMed] [Google Scholar]
  44. Kiani R., Johnson D., Nelson B. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Am J Med. 1988 Sep 16;85(3A):6–13. doi: 10.1016/0002-9343(88)90457-3. [DOI] [PubMed] [Google Scholar]
  45. Lebel M. H., Hoyt M. J., McCracken G. H., Jr Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr. 1989 Jun;114(6):1049–1054. doi: 10.1016/s0022-3476(89)80462-7. [DOI] [PubMed] [Google Scholar]
  46. Lee S., Spira S., Gabor E. P. Coagulopathy associated with moxalactam. JAMA. 1983 Apr 15;249(15):2019–2020. [PubMed] [Google Scholar]
  47. Livermore D. M. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol. 1987 Aug;6(4):439–445. doi: 10.1007/BF02013107. [DOI] [PubMed] [Google Scholar]
  48. Livermore D. M. Mechanisms of resistance to cephalosporin antibiotics. Drugs. 1987;34 (Suppl 2):64–88. doi: 10.2165/00003495-198700342-00007. [DOI] [PubMed] [Google Scholar]
  49. Malangoni M. A., Condon R. E., Spiegel C. A. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy. Surgery. 1985 Oct;98(4):648–655. [PubMed] [Google Scholar]
  50. Mandell L. A., Bergeron M. G., Ronald A. R., Vega C., Harding G., Saginur R., Feld R., Duperval R., Landis S. J., Miedzinski L. J. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. J Infect Dis. 1989 Sep;160(3):433–441. doi: 10.1093/infdis/160.3.433. [DOI] [PubMed] [Google Scholar]
  51. Marks W. A., Stutman H. R., Marks M. I., Abramson J. S., Ayoub E. M., Chartrand S. A., Cox F. E., Geffen W. A., Harrison C. J., Harrison D. Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr. 1986 Jul;109(1):123–130. doi: 10.1016/s0022-3476(86)80591-1. [DOI] [PubMed] [Google Scholar]
  52. Martens M. G. Cephalosporins. Obstet Gynecol Clin North Am. 1989 Jun;16(2):291–304. [PubMed] [Google Scholar]
  53. Marx M. A., Fant W. K. Cefuroxime axetil. Drug Intell Clin Pharm. 1988 Sep;22(9):651–658. doi: 10.1177/106002808802200901. [DOI] [PubMed] [Google Scholar]
  54. McEniry D. W., Gorbach S. L. Cephalosporins in surgery. Prophylaxis and therapy. Drugs. 1987;34 (Suppl 2):216–239. doi: 10.2165/00003495-198700342-00016. [DOI] [PubMed] [Google Scholar]
  55. McLinn S. E. Randomized, open label, multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion. Pediatr Infect Dis J. 1987 Oct;6(10):997–1001. doi: 10.1097/00006454-198710000-00042. [DOI] [PubMed] [Google Scholar]
  56. Minami S., Yotsuji A., Inoue M., Mitsuhashi S. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother. 1980 Sep;18(3):382–385. doi: 10.1128/aac.18.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Munro R., Sorrell T. C. Biliary sepsis. Reviewing treatment options. Drugs. 1986 May;31(5):449–454. doi: 10.2165/00003495-198631050-00004. [DOI] [PubMed] [Google Scholar]
  58. Neu H. C. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime. Rev Infect Dis. 1982 Sep-Oct;4 (Suppl):S374–S378. doi: 10.1093/clinids/4.supplement_2.s374. [DOI] [PubMed] [Google Scholar]
  59. Neu H. C. Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use. Pharmacotherapy. 1984 Mar-Apr;4(2):47–60. doi: 10.1002/j.1875-9114.1984.tb03313.x. [DOI] [PubMed] [Google Scholar]
  60. Neu H. C. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams. Curr Clin Top Infect Dis. 1987;8:37–61. [PubMed] [Google Scholar]
  61. Nichols R. L., Smith J. W., Klein D. B., Trunkey D. D., Cooper R. H., Adinolfi M. F., Mills J. Risk of infection after penetrating abdominal trauma. N Engl J Med. 1984 Oct 25;311(17):1065–1070. doi: 10.1056/NEJM198410253111701. [DOI] [PubMed] [Google Scholar]
  62. Nichols R. L., Wikler M. A., McDevitt J. T., Lentnek A. L., Hosutt J. A. Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections. Antimicrob Agents Chemother. 1987 Feb;31(2):281–285. doi: 10.1128/aac.31.2.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Norrby S. R. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime. Am J Med. 1985 Aug 9;79(2A):56–61. doi: 10.1016/0002-9343(85)90262-1. [DOI] [PubMed] [Google Scholar]
  64. Norrby S. R. Side effects of cephalosporins. Drugs. 1987;34 (Suppl 2):105–120. doi: 10.2165/00003495-198700342-00009. [DOI] [PubMed] [Google Scholar]
  65. Odenholt I., Isaksson B., Nilsson L., Cars O. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1989 Feb;8(2):136–141. doi: 10.1007/BF01963897. [DOI] [PubMed] [Google Scholar]
  66. Parks D., Layne P., Uri J., Ziv D., Bass S. Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A. J Antimicrob Chemother. 1982 Nov;10 (Suppl 100):327–338. doi: 10.1093/jac/10.suppl_c.327. [DOI] [PubMed] [Google Scholar]
  67. Quin J. D. The nephrotoxicity of cephalosporins. Adverse Drug React Acute Poisoning Rev. 1989 Summer;8(2):63–72. [PubMed] [Google Scholar]
  68. Rankin G. O., Sutherland C. H. Nephrotoxicity of aminoglycosides and cephalosporins in combination. Adverse Drug React Acute Poisoning Rev. 1989 Summer;8(2):73–88. [PubMed] [Google Scholar]
  69. Sanders C. C., Sanders W. E., Jr Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Rev Infect Dis. 1983 Jul-Aug;5(4):639–648. doi: 10.1093/clinids/5.4.639. [DOI] [PubMed] [Google Scholar]
  70. Sanders C. V., Greenberg R. N., Marier R. L. Cefamandole and cefoxitin. Ann Intern Med. 1985 Jul;103(1):70–78. doi: 10.7326/0003-4819-103-1-70. [DOI] [PubMed] [Google Scholar]
  71. Schwartz B., Al-Tobaiqi A., Al-Ruwais A., Fontaine R. E., A'ashi J., Hightower A. W., Broome C. V., Music S. I. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet. 1988 Jun 4;1(8597):1239–1242. doi: 10.1016/s0140-6736(88)92069-7. [DOI] [PubMed] [Google Scholar]
  72. Smith C. R., Ambinder R., Lipsky J. J., Petty B. G., Israel E., Levitt R., Mellits E. D., Rocco L., Longstreth J., Lietman P. S. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Ann Intern Med. 1984 Oct;101(4):469–477. doi: 10.7326/0003-4819-101-4-469. [DOI] [PubMed] [Google Scholar]
  73. Smith C. R., Petty B. G., Hendrix C. W., Kernan W. N., Garver P. L., Fox K., Beamer A., Carbone K., Threlkeld M., Lietman P. S. Ceftriaxone compared with cefotaxime for serious bacterial infections. J Infect Dis. 1989 Sep;160(3):442–447. doi: 10.1093/infdis/160.3.442. [DOI] [PubMed] [Google Scholar]
  74. Smith G. H. Oral cephalosporins in perspective. DICP. 1990 Jan;24(1):45–51. doi: 10.1177/106002809002400111. [DOI] [PubMed] [Google Scholar]
  75. Soe G. B., Overturf G. D. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis. 1987 Jul-Aug;9(4):719–736. doi: 10.1093/clinids/9.4.719. [DOI] [PubMed] [Google Scholar]
  76. Steele R. W., Bradsher R. W. Comparison of ceftriaxone with standard therapy for bacterial meningitis. J Pediatr. 1983 Jul;103(1):138–141. doi: 10.1016/s0022-3476(83)80801-4. [DOI] [PubMed] [Google Scholar]
  77. Sweet R. L., Gall S. A., Gibbs R. S., Hemsell D. L., Knuppel R. A., Lane T. W., Miller R. D., Newton E. R., Poindexter A. N., Reguero W. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections. Am J Surg. 1988 May 31;155(5A):56–60. doi: 10.1016/s0002-9610(88)80214-9. [DOI] [PubMed] [Google Scholar]
  78. Tally F. P., McGowan K., Kellum J. M., Gorbach S. L., O'Donnell T. F. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg. 1981 Mar;193(3):318–323. doi: 10.1097/00000658-198103000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Taylor D. N., Pitarangsi C., Echeverria P., Panikabutra K., Suvongse C. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis. 1985 Nov;152(5):1002–1006. doi: 10.1093/infdis/152.5.1002. [DOI] [PubMed] [Google Scholar]
  80. Uri J. V., Parks D. B. Disulfiram-like reaction to certain cephalosporins. Ther Drug Monit. 1983 Jun;5(2):219–224. doi: 10.1097/00007691-198306000-00013. [DOI] [PubMed] [Google Scholar]
  81. Vogelman B., Gudmundsson S., Turnidge J., Leggett J., Craig W. A. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect Dis. 1988 Feb;157(2):287–298. doi: 10.1093/infdis/157.2.287. [DOI] [PubMed] [Google Scholar]
  82. Ward A., Richards D. M. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985 Nov;30(5):382–426. doi: 10.2165/00003495-198530050-00002. [DOI] [PubMed] [Google Scholar]
  83. Warren J. W., Miller E. H., Jr, Fitzpatrick B., DiFranco D. E., Caplan E. S., Tenney J. H., Anthony W. C. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev Infect Dis. 1983 Mar-Apr;5 (Suppl 1):S173–S180. doi: 10.1093/clinids/5.supplement_1.s173. [DOI] [PubMed] [Google Scholar]
  84. Wasilauskas B. L. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis. Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):39–43. doi: 10.1016/0732-8893(89)90044-8. [DOI] [PubMed] [Google Scholar]
  85. Weitekamp M. R., Aber R. C. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA. 1983 Jan 7;249(1):69–71. [PubMed] [Google Scholar]
  86. Welage L. S., Hejmanowski L. G., Wilton J. H., Walawander C., Rigan D., Williams J. S., Schentag J. J. Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan. Antimicrob Agents Chemother. 1989 Jun;33(6):857–861. doi: 10.1128/aac.33.6.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Williams J. D., Moosdeen F. In vitro antibacterial effects of cephalosporins. Drugs. 1987;34 (Suppl 2):44–63. doi: 10.2165/00003495-198700342-00006. [DOI] [PubMed] [Google Scholar]
  88. Wilson S. E., Boswick J. A., Jr, Duma R. J., Echols R. M., Jemsek J. G., Lerner R., Lewis R. T., Najem A. Z., Press R. A., Rittenbury M. S. Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin. Am J Surg. 1988 May 31;155(5A):61–66. doi: 10.1016/s0002-9610(88)80215-0. [DOI] [PubMed] [Google Scholar]
  89. del Rio M. A., Chrane D., Shelton S., McCracken G. H., Jr, Nelson J. D. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet. 1983 Jun 4;1(8336):1241–1244. doi: 10.1016/s0140-6736(83)92696-x. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES